Healthcare Finance News (3/8, Lagasse ) reported, “At a rate of 72.3%, patients receiving opioid treatment through in-network insurance overwhelmingly stayed in treatment for at least 180 days, in comparison with those who were either out-of-network or uninsured and paying for treatment with cash, a new study finds.” Published in Health Affairs Scholar, the study found that “compared to cash-pay patients, those who could use in-network benefits had almost twice the retention rate for six months of treatment, a quality benchmark established by the Centers for Medicare and Medicaid Services.” Additionally, “uninsured cash-pay patients had a 48.1% retention rate, which was higher than the 37% six-month retention rate of insured out-of-network cash-pay patients.”
Related Links:
— “Insurance coverage improves opioid use disorder treatment retention,”Jeff Lagasse, Healthcare Finance News, March 8, 2024